| Open Label Study to Evaluate Ciprofloxacin/Celecoxib Combination in Patients With ALS (NCT04165850) | NeuroSense Therapeutics Ltd. | 2019-11-25 |
| Tripterygium Wilfordii Hook F and Methotrexate for Postmenopausal Women With Rheumatoid Arthritis (NCT04136262) | Guang'anmen Hospital of China Academy of Chinese Medical Sciences | 2019-11-25 |
| RGI-2001 for the Prevention of Acute Graft-vs-Host Disease in Subjects Following Allogeneic Hematopoietic Stem Cell Transplantation (NCT04014790) | Regimmune Corporation | 2019-11-25 |
| Checkpoint Inhibitors and SBRT for MCRPC (NCT05655715) | Herlev and Gentofte Hospital | 2019-11-25 |
| Efficacy and Safety of LNP023 Compared With Rituximab in Subjects With Idiopathic Membranous Nephropathy (NCT04154787) | Novartis Pharmaceuticals | 2019-11-23 |
| Bacillus Calmette-Guérin (BCG) and Gemcitabine in People With High-Grade Non-Muscle Invasive Bladder Cancer That Came Back After BCG Treatment (NCT04179162) | Memorial Sloan Kettering Cancer Center | 2019-11-22 |
| Study to Evaluate the Safety and Efficacy of Lenacapavir (GS-6207) in Combination With Other Antiretroviral Agents in People Living With HIV (NCT04143594) | Gilead Sciences | 2019-11-22 |
| Extracorporeal Photopheresis of Patients With Crohn's Disease Using 5-aminolevulinic Acid (NCT04164849) | University Hospital, Akershus | 2019-11-22 |
| Imaging of Tumour Microenvironment in Patients With Oropharyngeal Head and Neck Squamous Cell Carcinoma Using RGD PET/CT Imaging (NCT04222543) | Radboud University Medical Center | 2019-11-22 |
| Study of Anlotinib Plus Chemoradiotherapy in Patients With Locally Advanced NSCLC (NCT04182698) | Second Affiliated Hospital of Xi'an Jiaotong University | 2019-11-22 |
| A Comparison of the Effects of ORP-101 Versus Placebo in Adult Patients With Irritable Bowel Syndrome With Diarrhea (IBS-D) (NCT04129619) | OrphoMed, Inc. | 2019-11-22 |
| A Study Evaluating the Efficacy and Safety of HSK3486 for Sedation (NCT04147416) | Sichuan Haisco Pharmaceutical Group Co., Ltd | 2019-11-22 |
| Pinhole Surgical Technique for Root Coverage Using PRF (NCT04202198) | Krishnadevaraya College of Dental Sciences & Hospital | 2019-11-22 |
| Intra-patient Dose Escalation Study to Investigate Safety and Feasibility of Vactosertib in Treating Anemic MPN Patients (NCT04103645) | Weill Medical College of Cornell University | 2019-11-22 |
| Daratumumab Based Response Adapted Therapy for Older Adults With Newly Diagnosed Multiple Myeloma (NCT04151667) | H. Lee Moffitt Cancer Center and Research Institute | 2019-11-22 |
| Trial Evaluating the Clinical Efficacy of Cefixime for Treatment of Early Syphilis in Non-pregnant Women (NCT03752112) | World Health Organization | 2019-11-22 |
| Chemoradiotherapy for Advanced Esophageal Cancer (NCT02297217) | AHS Cancer Control Alberta | 2019-11-21 |
| DP13 - A Phase II Study in Patients With Primary Aldosteronism (NCT04007406) | Damian Pharma AG | 2019-11-21 |
| NPC-06 to Acute Pain in Herpes Zoster (NCT04139330) | Nobelpharma | 2019-11-21 |
| Valemetostat Tosylate (DS-3201b) Phase 2 Study in Relapsed or Refractory Adult T-cell Leukemia/Lymphoma (NCT04102150) | Daiichi Sankyo Co., Ltd. | 2019-11-21 |
| SMART Use of Medication for the Treatment of Adolescent Severe Obesity (NCT04007393) | University of Minnesota | 2019-11-21 |
| A Study of TACI-antibody Fusion Protein Injection (RC18) in Subjects With Primary Sjögren's Syndrome (NCT04078386) | RemeGen Co., Ltd. | 2019-11-21 |
| Phase 2a Pilot Study of NBMI Treatment in Patients With Beta Thalassemia Major, Requiring Iron Chelation (NCT04092205) | EmeraMed | 2019-11-21 |
| Apremilast - Oral Lichen Planus Trial (NCT03836885) | Sunnybrook Health Sciences Centre | 2019-11-21 |
| Study to Evaluate the Safety and Efficacy of Lenacapavir (GS-6207) in Combination With an Optimized Background Regimen (OBR) in Heavily Treatment Experienced Participants Living With HIV-1 Infection With Multidrug Resistance (NCT04150068) | Gilead Sciences | 2019-11-21 |
| Safety, Tolerability and Pharmacokinetics Characteristics of Recombinant Oncolytic Vaccinia Virus Injection T601 as a Single Drug or in Combination With Oral Flucytosine (5-FC), in Patients With Advanced Malignant Solid Tumors (NCT04226066) | Tasly Tianjin Biopharmaceutical Co., Ltd. | 2019-11-20 |
| Clinical Study of Propranolol Combined With Neoadjuvant Chemotherapy in Gastric Cancer (NCT04005365) | Yijing He | 2019-11-20 |
| Higher Doses of Botulinum Toxin in the Treatment of Gummy Smile (NCT05127018) | Peking University | 2019-11-20 |
| Safety and Efficacy of SofWave Treatment to Lift Lax Tissue in the Submental and Neck Zones and to Lift the Eyebrow (NCT04146584) | Sofwave Medical LTD | 2019-11-20 |
| Glecaprevir/Pibrentasvir Fixed-dose Combination Treatment for Acute Hepatitis C Virus Infection (NCT04042740) | Advancing Clinical Therapeutics Globally for HIV/AIDS and Other Infections | 2019-11-20 |
| Impact of CCH Treatment of Buttock and Thigh Cellulite in Adult Women (NCT04209530) | Endo USA Inc., a Keenova Therapeutics Company | 2019-11-20 |
| Nab-paclitaxel Plus Carboplatin Versus Nab-paclitaxel Plus Epirubicin in the Neoadjuvant Therapy for Breast Cancer (NCT04138719) | Hebei Medical University Fourth Hospital | 2019-11-20 |
| Anti-PD-1 Antibody Plus DEB-TACE for BCLC Stage A/B HCC (NCT04174781) | Zhejiang University | 2019-11-20 |
| PROCLAIM: CX-072-002: Study of PD-L1 Probody Therapeutic CX-072 in Combination With Other Anticancer Therapy in Adults With Solid Tumors (NCT03993379) | CytomX Therapeutics | 2019-11-20 |
| Evaluating the Safety and Effect of abobotulinumtoxinA in the Gastrocnemius Muscle to Improve Equinus and Plantar Fasciitis Pain (NCT03978234) | University Foot and Ankle Foundation | 2019-11-20 |
| Safety and Efficacy of IGIV 10% in Patients With Autoimmune Encephalitis: (NCT04175522) | Green Cross Corporation | 2019-11-20 |
| Nab-paclitaxel Plus Carboplatin Versus Nab-paclitaxel Plus Capecitabine in the Treatment of Advanced Triple-negative Breast Cancer (NCT04159142) | Hebei Medical University Fourth Hospital | 2019-11-20 |
| A Phase II Study of Total Neoadjuvant Therapy for Locally Advanced Gastric Cancer (NCT04062058) | Jing Jin, M.D. | 2019-11-20 |
| Perioperative Intervention to Reduce Metastatic Processes in Pancreatic Cancer Patients Undergoing Curative Surgery (NCT03838029) | Assaf-Harofeh Medical Center | 2019-11-20 |
| A Study of Erdafitinib in Participants With Advanced Solid Tumors and Fibroblast Growth Factor Receptor (FGFR) Gene Alterations (NCT04083976) | Janssen Research & Development, LLC | 2019-11-20 |
| Perioperative Atezolizumab With MVA-BN-Brachyury and PROSTVAC For Intermediate-Risk And High-Risk Localized Prostate Cancer (NCT04020094) | University of Utah | 2019-11-20 |
| Pentoxifylline, Atorvastatin, and Vitamin E in Treating Patients With Erectile Dysfunction After Radiation Therapy for Prostate Cancer (NCT03830164) | M.D. Anderson Cancer Center | 2019-11-20 |
| Olaparib for PAH: a Multicenter Clinical Trial (NCT03782818) | Laval University | 2019-11-20 |
| Phase 2 Open-label Study of Alum-adjuvanted Chikungunya Virus-like Particle Vaccine (PXVX0317) (NCT03992872) | Bavarian Nordic | 2019-11-20 |
| Effect of Ketamine Intranasal Spray in Treatment of Chronic Cluster Headache (NCT04179266) | CCH Pharmaceuticals | 2019-11-20 |
| Cell Therapy Associated With Endobronchial Valve (NCT04018729) | Hospital de Clinicas de Porto Alegre | 2019-11-19 |
| Combination of E-cigarettes and Varenicline for Tobacco Harm Reduction (NCT04210180) | Rose Research Center, LLC | 2019-11-19 |
| A Study of Tirzepatide (LY3298176) in Participants With Nonalcoholic Steatohepatitis (NASH) (NCT04166773) | Eli Lilly and Company | 2019-11-19 |
| Nicotinamide Riboside Supplementation for Treating Arterial Stiffness and Elevated Systolic Blood Pressure in Patients With Moderate to Severe CKD (NCT04040959) | University of Colorado, Denver | 2019-11-19 |
| Study of RV001V in Biochemical Failure Following Curatively Intended Therapy For Localized Prostate Cancer (NCT04114825) | RhoVac APS | 2019-11-19 |
| Immunotherapy, Chemotherapy, Radiotherapy and Surgery for Synchronous Oligo-metastatic NSCLC (NCT03965468) | ETOP IBCSG Partners Foundation | 2019-11-19 |
| Systemic Chemotherapy Plus Lenvatinib and Toripalimab for HCC With Extrahepatic Metastasis (NCT04170179) | Sun Yat-sen University | 2019-11-19 |
| Alterations in the Vaginal Microenvironment Using a Non-pharmacological Intervention (NCT03739983) | University of Wisconsin, Madison | 2019-11-19 |
| Treatment Free Remission After Combination Therapy With Ruxolitinib Plus Tyrosine Kinase Inhibitors (NCT03610971) | H. Lee Moffitt Cancer Center and Research Institute | 2019-11-19 |
| Graft Versus Host Disease-Reduction Strategies for Donor Blood Stem Cell Transplant Patients With Acute Leukemia or Myelodysplastic Syndrome (MDS) (NCT03970096) | Fred Hutchinson Cancer Center | 2019-11-19 |
| A Study of Lenalidomide and CC-486 With Radiation Therapy in Patients With Plasmacytoma (NCT04174196) | Memorial Sloan Kettering Cancer Center | 2019-11-19 |
| Study of Olaparib (MK-7339) in Combination With Pembrolizumab (MK-3475) in the Treatment of Homologous Recombination Repair Mutation (HRRm) and/or Homologous Recombination Deficiency (HRD)-Positive Advanced Cancer (MK-7339-007/KEYLYNK-007) (NCT04123366) | Merck Sharp & Dohme LLC | 2019-11-18 |
| A Study of TQ-A3334 Combined With Entecavir in the Treatment of Chronic Hepatitis B (NCT04180150) | Chia Tai Tianqing Pharmaceutical Group Co., Ltd. | 2019-11-18 |
| Study to Evaluate the Safety and Efficacy ofJaktinib Hydrochloride Tablets in Severe Alopecia Areata (NCT04034134) | Suzhou Zelgen Biopharmaceuticals Co.,Ltd | 2019-11-18 |
| A Study of PCSK9 Inhibitor AK102 in Patients With Heterozygous Familial Hypercholesterolemia (HeFH) (NCT04173793) | Akeso | 2019-11-18 |
| A Phase 2b Diabetic Kidney Disease Study (NCT04170543) | AstraZeneca | 2019-11-18 |
| Early Treatment With Evolocumab in Patients With ST-elevation Myocardial Infarction (NCT04303377) | Fondazione IRCCS Policlinico San Matteo di Pavia | 2019-11-18 |
| A Study of Tyrosine Kinase Inhibitor Orelabrutinib (ICP-022) in Patients With r/r B-Cell Malignancies (NCT04014205) | Beijing InnoCare Pharma Tech Co., Ltd. | 2019-11-18 |
| A Study of Tazemetostat With Enzalutamide or Abiraterone/Prednisone in Participants With Advanced Prostate Cancer (NCT04179864) | Epizyme, Inc. | 2019-11-18 |
| Rivastigmine Patch Compared to Melatonin Patch in Prevention of Postoperative Delirium (NCT04189666) | Ain Shams University | 2019-11-18 |
| Glumetinib Combined With Osimertinib in the Treatment of Relapsed and Metastatic Non-small Cell Lung Cancer Patients Who Failed to Receive EGFR Inhibitors (NCT04338243) | Haihe Biopharma Co., Ltd. | 2019-11-18 |
| Single-Fraction SBRT Versus Standard Palliative Radiation Therapy in Treating Patients With Metastatic Cancer (NCT04068649) | Roswell Park Cancer Institute | 2019-11-18 |
| Testing the Addition of Tazemetostat to the Immunotherapy Drug, Pembrolizumab (MK-3475), in Advanced Urothelial Carcinoma (NCT03854474) | National Cancer Institute (NCI) | 2019-11-18 |
| Toripalimab Plus Stereotactic Body Radiotherapy for HCC With PVTT (NCT04169399) | Sun Yat-sen University | 2019-11-17 |
| Combination of Sintilimab and Stereotactic Body Radiotherapy in Hepatocellular Carcinoma (ISBRT01) (NCT04167293) | Mian XI | 2019-11-16 |
| Efficacy and Safety Study of Anlotinib With Pembrolizumab in Adults With Programmed Cell Death-Ligand 1 (PD-L1)-Positive Treatment-naïve Non-small Cell Lung Cancer (NCT04164745) | Peking Union Medical College Hospital | 2019-11-16 |
| A Phase II Open-label Single-arm Study to Evaluate the Efficacy and Safety of ADSCs in Subjects With Liver Cirrhosis (NCT04088058) | Gwo Xi Stem Cell Applied Technology Co., Ltd. | 2019-11-16 |
| Sintilimab and Nab-paclitaxel in Second-line Treatment of Advanced Gastric or Gastro-oesophageal Junction Adenocarcinoma (NCT04140318) | Chinese Academy of Medical Sciences | 2019-11-15 |
| Monoclonal Antibody Therapy Against Chronic Herpes Simplex Virus 2 Infection (NCT04165122) | Heidelberg ImmunoTherapeutics GmbH | 2019-11-15 |
| HDM201 Added to CT in R/R or Newly Diagnosed AML (NCT03760445) | Novartis Pharmaceuticals | 2019-11-15 |
| Concurrent Nivolumab and External Beam Radiation Therapy for Patients With Advanced HCC (NCT04611165) | National Cancer Center, Korea | 2019-11-15 |
| Efficacy of Plasmid Elenagen in Combination With Gemcitabine in Patients With Platinum-resistant Ovarian Cancer (NCT05979298) | CureLab Oncology | 2019-11-15 |
| Oral Prednisolone Effect on Cancer WHO Stepladder Analgesia Protocol (NCT04162379) | Mansoura University | 2019-11-15 |
| A Study of LY3454738 in Adults With Chronic Spontaneous Urticaria (NCT04159701) | Eli Lilly and Company | 2019-11-15 |
| Ruxolitinib in Treating Patients With Hypereosinophilic Syndrome or Primary Eosinophilic Disorders (NCT03801434) | William Shomali | 2019-11-15 |
| MTT for Children With ASD Who Have Gastrointestinal Disorders (NCT04182633) | Arizona State University | 2019-11-15 |
| Levobupivacaine vs Levobupivacaine + Dexmedetomidine Infiltration for Post-tonsillectomy Analgesia and Laryngospasm in Pediatric Patients (NCT04113720) | Assiut University | 2019-11-15 |
| Effect of Intravenous Dexmedetomidine on Patient Discomfort in Laparoscopic Cholecystectomy Under Spinal Anesthesia. (NCT04115449) | Theodor Bilharz Research Institute | 2019-11-15 |
| Stem Cell Transplantation in Crohn's Disease (NCT04224558) | Cedars-Sinai Medical Center | 2019-11-15 |
| The Study of Gemcitabine Plus Nab-Paclitaxel in Combination With Pegvorhyaluronidase Alfa (PVHA; PEGPH20) and Pembrolizumab as Front-line Treatment for Metastatic Pancreatic Adenocarcinoma. (NCT04045730) | Yale University | 2019-11-15 |
| Healthy Heart Habits (NCT04158219) | Hennepin Healthcare Research Institute | 2019-11-15 |
| Clinical Trial to Evaluate the Safety and Efficacy of JP-1366 in Patients With Erosive Gastroesophageal Reflux Disease (NCT04282954) | Onconic Therapeutics Inc. | 2019-11-15 |
| CELTIC-1: A Phase 2B Study of Cerdulatinib in Patients With Relapsed/Refractory Peripheral T-Cell Lymphoma (PTCL) (NCT04021082) | Portola Pharmaceuticals | 2019-11-15 |
| Anlotinib Hydrochloride Capsules Combined With CAPEOX in RAS and BRAF Wild-type mCRC Patients (NCT04080843) | Zhejiang University | 2019-11-15 |
| A Study to Assess the Efficacy and Safety of VK2809 for 52 Weeks in Subjects With Biopsy Proven NASH (NCT04173065) | Viking Therapeutics, Inc. | 2019-11-15 |
| BTZ-043 - Multiple Ascending Dose (MAD) to Evaluate Safety, Tolerability and Early Bactericidal Activity (EBA) (NCT04044001) | Michael Hoelscher | 2019-11-15 |
| BrUOG 379 Phase Ib/II Trial ONC201 + Nivolumab in MSS mCRC (NCT03791398) | Brown University | 2019-11-15 |
| Clinical Study of Intra Articular Injection of Catholic MASTER Cell (Bone Marrow Derived Mesenchymal Stem Cell) in Knee Osteoarthritis (NCT04240873) | Seoul St. Mary's Hospital | 2019-11-15 |
| Systems Biology of Zoster Vaccine (NCT04047979) | Emory University | 2019-11-14 |
| This Phase II/III, Multicenter Study is Designed to Evaluate the Safety and Clinical Activity of AL3810 in Patients (NCT04254471) | Haihe Biopharma Co., Ltd. | 2019-11-14 |
| Safety and IOP-Lowering Effects of WB007 (NCT04149899) | Bausch & Lomb Incorporated | 2019-11-14 |
| PD-1 Monoclonal Antibody, Lenvatinib and TACE in the Treatment of HCC (NCT04273100) | Tianjin Medical University Cancer Institute and Hospital | 2019-11-14 |
| A Phase II Study of Chemoradiotherapy With Nimotuzumab in Unresectable Esophageal Cancer (NCT04207918) | Cancer Institute and Hospital, Chinese Academy of Medical Sciences | 2019-11-14 |
| Modified Atkins Diet Versus Levetiracetam for Refractory Childhood Epilepsy (NCT04172311) | Lady Hardinge Medical College | 2019-11-14 |
| tDCS and Female Urinary Incontinence (NCT04084340) | Universidade Federal do Piauí | 2019-11-14 |